Conclusion
Outcomes for HNSCCUP patients undergoing ND alone range widely in the
literature but appear reasonable in a subset of patients with early
stage p16 positive disease. Data is lacking for p16 negative disease
where the potential primary site is more varied and primary emergence
appears more common.